Taprostene sodium
- Level
- Commodity
- Parent
- 51131700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131754This classification denotes an antiplatelet agent with the molecular formula C24H29O5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3M078713KZ, chemically known as benzoic acid, 3-((z)-((3ar,4r,5r,6as)-4-((1e,3s)-3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2h-cyclopenta(b)furan-2-ylidene)methyl)-, monosodium salt, but more generally known as taprostene sodium, which bears US NIH Compound Identifier 6437844. European Medicines Agency schedules taprostene sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10831MIG. Most nations, for tariff purposes, schedule taprostene sodium under HS 29375000. SMILES: C1CC(CC(C1)C(=O)[O-])/C=C\2/C[C@H]3[C@@H](O2)C[C@H]([C@@H]3/C=C/[C@H](C4CCCCC4)O)O.[NA+].
Same parent
Under 51131700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.